• Standex’s FY27 first-quarter diluted earnings per share from continuing operations jumped 60% year over year to $1.99.
• Net sales rose 7% year over year to $232.6 million, while order intake reached a record approximately $273 million.
• The board authorized a new $100 million share repurchase program, replacing the prior authorization.
• FY27 net sales growth is now forecast at high single digits, up from mid-to-high single digits previously.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Standex International Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: NY84805) on October 29, 2026, and is solely responsible for the information contained therein.